Consistent with our results, omeprazole treatment increases the frequency of CD4+ CD25+ FoxP3+ Treg cells and decreases the frequency of CD4+ IL-17A+ T cells among peripheral blood mononuclear cells (PBMCs) of patients with duodenal ulcers. Here, IL17A is linked to duodenal ulcer.